Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands |
Total |
Public and Placement Warrants |
Previously Reported |
Revision of Prior Period, Adjustment |
Preferred Class A |
Total Stockholders' Equity (Deficit) |
Total Stockholders' Equity (Deficit)
Public and Placement Warrants
|
Total Stockholders' Equity (Deficit)
Previously Reported
|
Total Stockholders' Equity (Deficit)
Revision of Prior Period, Adjustment
|
Total Stockholders' Equity (Deficit)
Preferred Class A
|
Common Stock |
Common Stock
Public and Placement Warrants
|
Common Stock
Previously Reported
|
Common Stock
Revision of Prior Period, Adjustment
|
Additional Paid-in Capital |
Additional Paid-in Capital
Public and Placement Warrants
|
Additional Paid-in Capital
Previously Reported
|
Additional Paid-in Capital
Revision of Prior Period, Adjustment
|
Additional Paid-in Capital
Preferred Class A
|
Accumulated Deficit |
Accumulated Deficit
Previously Reported
|
Accumulated Deficit
Preferred Class A
|
Non Controlling Interests |
Non Controlling Interests
Previously Reported
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance (in shares) at Dec. 31, 2020 | 89,999,976 | 1,029 | 89,998,947 | |||||||||||||||||||||
Beginning balance at Dec. 31, 2020 | $ 138,995 | $ (64,752) | $ 203,747 | $ 124,979 | $ (78,768) | $ 203,747 | $ 9 | $ 1 | $ 8 | $ 205,772 | $ 2,033 | $ 203,739 | $ (80,802) | $ (80,802) | $ 14,016 | $ 14,016 | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||
Issuance of Series A preferred stock | $ 82,000 | $ 82,000 | $ 82,000 | |||||||||||||||||||||
Cash contributions from noncontrolling interests | 2,708 | 2,708 | ||||||||||||||||||||||
Accretion of Series A preferred stock | 0 | 1,616 | $ (1,616) | |||||||||||||||||||||
Stock-based compensation | 111 | 111 | 111 | |||||||||||||||||||||
Accrued dividends and commitment fees on Series A preferred stock | 0 | 13,584 | (13,584) | |||||||||||||||||||||
Payment of dividends and commitment fees on Series A preferred stock | (17,747) | (17,747) | (17,747) | |||||||||||||||||||||
Cash distributions to noncontrolling interests | (1,093) | (1,093) | ||||||||||||||||||||||
Accrued distributions to noncontrolling interests | 0 | 0 | ||||||||||||||||||||||
Redemption of redeemable noncontrolling interests | 1,031 | 1,031 | 1,031 | |||||||||||||||||||||
Noncontrolling interests assumed through acquisitions | 4,315 | 4,315 | ||||||||||||||||||||||
Net income (loss) | (799) | (1,282) | (1,282) | 483 | ||||||||||||||||||||
Ending balance (in shares) at Sep. 30, 2021 | 89,999,976 | |||||||||||||||||||||||
Ending balance at Sep. 30, 2021 | 209,521 | 189,092 | $ 9 | 286,367 | (97,284) | 20,429 | ||||||||||||||||||
Beginning balance (in shares) at Jun. 30, 2021 | 89,999,976 | |||||||||||||||||||||||
Beginning balance at Jun. 30, 2021 | 131,017 | 116,450 | $ 9 | 207,021 | (90,580) | 14,567 | ||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||
Issuance of Series A preferred stock | 82,000 | 82,000 | 82,000 | |||||||||||||||||||||
Cash contributions from noncontrolling interests | 2,269 | 2,269 | ||||||||||||||||||||||
Accretion of Series A preferred stock | 0 | 545 | (545) | |||||||||||||||||||||
Stock-based compensation | 34 | 34 | 34 | |||||||||||||||||||||
Accrued dividends and commitment fees on Series A preferred stock | 0 | 5,104 | $ (5,104) | |||||||||||||||||||||
Payment of dividends and commitment fees on Series A preferred stock | $ (9,368) | $ (9,368) | $ (9,368) | |||||||||||||||||||||
Cash distributions to noncontrolling interests | (487) | (487) | ||||||||||||||||||||||
Accrued distributions to noncontrolling interests | 145 | 145 | ||||||||||||||||||||||
Redemption of redeemable noncontrolling interests | 1,031 | 1,031 | 1,031 | |||||||||||||||||||||
Noncontrolling interests assumed through acquisitions | 4,315 | 4,315 | ||||||||||||||||||||||
Net income (loss) | (1,435) | (1,055) | (1,055) | (380) | ||||||||||||||||||||
Ending balance (in shares) at Sep. 30, 2021 | 89,999,976 | |||||||||||||||||||||||
Ending balance at Sep. 30, 2021 | $ 209,521 | 189,092 | $ 9 | 286,367 | (97,284) | 20,429 | ||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2021 | 153,648,830 | 153,648,830 | ||||||||||||||||||||||
Beginning balance at Dec. 31, 2021 | $ 326,011 | 304,918 | $ 15 | 406,259 | (101,356) | 21,093 | ||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||
Cash contributions from noncontrolling interests | 2,133 | 2,133 | ||||||||||||||||||||||
Stock-based compensation | 6,670 | 6,670 | 6,670 | |||||||||||||||||||||
Cash distributions to noncontrolling interests | (1,188) | (1,188) | ||||||||||||||||||||||
Redemption of redeemable noncontrolling interests | (712) | (712) | (712) | |||||||||||||||||||||
Net income (loss) | (15,349) | (12,446) | (12,446) | (2,903) | ||||||||||||||||||||
Conversion of convertible securities (in shares) | 2,021 | 1,111,243 | ||||||||||||||||||||||
Conversion of convertible securities | 15 | $ 7,779 | 15 | $ 7,779 | 15 | $ 7,779 | ||||||||||||||||||
Exercised warrants (in shares) | 2,934,466 | |||||||||||||||||||||||
Exercised Warrants | $ 35,859 | 35,859 | $ 1 | 35,858 | ||||||||||||||||||||
Ending balance (in shares) at Sep. 30, 2022 | 157,696,560 | 157,696,560 | ||||||||||||||||||||||
Ending balance at Sep. 30, 2022 | $ 361,218 | 342,083 | $ 16 | 455,869 | (113,802) | 19,135 | ||||||||||||||||||
Beginning balance (in shares) at Jun. 30, 2022 | 154,718,268 | |||||||||||||||||||||||
Beginning balance at Jun. 30, 2022 | 418,720 | 400,025 | $ 15 | 416,832 | (16,822) | 18,695 | ||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||
Cash contributions from noncontrolling interests | 1,069 | 1,069 | ||||||||||||||||||||||
Stock-based compensation | 2,708 | 2,708 | 2,708 | |||||||||||||||||||||
Cash distributions to noncontrolling interests | (522) | (522) | ||||||||||||||||||||||
Net income (loss) | (97,087) | (96,980) | (96,980) | (107) | ||||||||||||||||||||
Conversion of convertible securities (in shares) | 0 | 43,826 | ||||||||||||||||||||||
Conversion of convertible securities | $ 471 | $ 471 | $ 471 | |||||||||||||||||||||
Exercised warrants (in shares) | 2,934,466 | |||||||||||||||||||||||
Exercised Warrants | $ 35,859 | 35,859 | $ 1 | 35,858 | ||||||||||||||||||||
Ending balance (in shares) at Sep. 30, 2022 | 157,696,560 | 157,696,560 | ||||||||||||||||||||||
Ending balance at Sep. 30, 2022 | $ 361,218 | $ 342,083 | $ 16 | $ 455,869 | $ (113,802) | $ 19,135 |